Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants
Clinical trial NCT06190691 · COMPLETED
Trial details
- NCT number
- NCT06190691
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2021-12-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.